Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye

NCT02746991 is registered in ClinicalTrials.gov with EyePoint Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02746991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02746991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Lead sponsor
EyePoint Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 2, 2015
Completion date
October 4, 2019
Enrollment
153 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

intermediate uveitis, panuveitis, posterior uveitis